Books, Original Papers & Review Papers- MORIMOTO Ryo -
number of results to view: what to display: sort:
[B]:Books [O]:Original Papers [R]:Review Papers
total:91
[2018]
1.[O] Effects of surgical treatment for acromegaly on knee MRI structural features..[Endocrine journal,(2018)]Nezu M, Kudo M, Morimoto R, Ono Y, Omata K, Tezuka Y, Igarashi Y, Hitachi S, Takase K, Ito S, Satoh F
10.1507/endocrj.EJ18-0108
http://www.ncbi.nlm.nih.gov/pubmed/30012912
2.[O] Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma..[Human pathology,77,(2018),88-97]Kitawaki Y, Nakamura Y, Kubota-Nakayama F, Yamazaki Y, Miki Y, Hata S, Ise K, Kikuchi K, Morimoto R, Satoh F, Sasano H
10.1016/j.humpath.2018.03.016
http://www.ncbi.nlm.nih.gov/pubmed/29596893
3.[O] Progress in the Management of Primary Aldosteronism..[American journal of hypertension,31(5),(2018),522-531]Morimoto R, Omata K, Ito S, Satoh F
10.1093/ajh/hpy018
http://www.ncbi.nlm.nih.gov/pubmed/29534182
4.[O] Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging..[European journal of radiology,98,(2018),150-157]Takahashi Y, Ota H, Omura K, Dendo Y, Otani K, Matsuura T, Kitami M, Seiji K, Tezuka Y, Nezu M, Ono Y, Morimoto R, Satoh F, Takase K
10.1016/j.ejrad.2017.11.017
http://www.ncbi.nlm.nih.gov/pubmed/29279155
[2017]
5.[O] Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.[JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM,102(4),(2017),1182-1192]Yuto Yamazaki, Yasuhiro Nakamura, Kei Omata, Kazue Ise, Yuta Tezuka, Yoshikiyo Ono, Ryo Morimoto, Yukinaga Nozawa, Celso E. Gomez-Sanchez, Scott A. Tomlins, William E. Rainey, Sadayoshi Ito, Fumitoshi Satoh, Hironobu Sasano
10.1210/jc.2016-2986
http://www.ncbi.nlm.nih.gov/pubmed/28388725 http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=TohokuUniv&SrcApp=TohokuUniv&DestLinkType=FullRecord&KeyUT=WOS:000402195300010&DestApp=WOS
6.[R] 血漿アルドステロン濃度および活性レニン濃度迅速測定系の概要とその臨床的意義.[臨床化学,46, (2017), 17-21]小野美澄、森本玲、山本幸子、赤羽和、手塚雄太、尾股慧、祢津昌広、五十嵐康宏、岩倉芳倫、工藤正孝、伊藤貞嘉、佐藤文俊
7.[R] 原発性アルドステロン症におけるハイブリッドステロイドの意義と将来性.[臨床化学,46, (2017), 34-38]手塚雄太、小野美澄、森本玲、岩倉芳倫、尾股慧、祢津昌広、工藤正孝、五十嵐康宏、伊藤貞嘉、佐藤文俊
8.[O] Anatomical Variations of the Right Adrenal Vein: Concordance Between Multidetector Computed Tomography and Catheter Venography..[Hypertension,69(3),(2017),428-434]Omura K, Ota H, Takahashi Y, Matsuura T, Seiji K, Arai Y, Morimoto R, Satoh F, Takase K
9.[O] Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient..[J Dermatol,(2017)]Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Haga T, Hashimoto A, Morimoto R, Aiba S
10.[O] Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort..[Lancet Diabetes Endocrinol,(2017)]Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators
11.[O] Rapid screening of primary aldosteronism by a novel chemiluminescent immunoassay..[Hypertension,(2017)]Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, Arai T, Gomez- Sanchez CE, Sasano H, Ito S, Satoh F
12.[O] Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma..[Oncotarget,(2017)]Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S
13.[R] Editorial Commentary: Aldosterone-Producing Adenomas : Genotype and Phenotypes..[Hypertension,70(1), (2017), 38-41]Satoh F, Sasano H, Yamazaki Y, Ito S
[2016]
14.[R] 【エキスパートオピニオン:副腎静脈サンプリングを考える】 副腎静脈サンプリングを考える 東北大学病院.[ホルモンと臨床 別冊,62(6), (2016), 443-449]森本玲、清治和将、伊藤貞嘉、高瀬圭、佐藤文俊
15.[O] Expression of steroidogenic enzymes and their transcription factors in cortisol-producing adrenocortical adenomas: immunohistochemical analysis and quantitative RT-PCR studies..[Hum Pathol,54,(2016),165-173]Kubota-Nakayama F, Nakamura Y, Konosu-Fukaya S, Azmahani A, Ise K, Yamazaki Y, Kitawaki Y, Felizola SJ, Ono Y, Omata K, Morimoto R, Iwama N, Satoh F, Sasano H
16.[O] Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis..[Hum Pathol,53,(2016),41-50]Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota F, Oki Y, Baba S, Midorikawa S, Morimoto R, Satoh F, Sasano H
17.[O] Renal Resistive Index Predicts Postoperative Blood Pressure Outcome in Primary Aldosteronism..[Hypertension,67(3),(2016),654-660]Iwakura Y, Ito S, Morimoto R, Kudo M, Ono Y, Nezu M, Takase K, Seiji K, Ishidoya S, Arai Y, Funamizu Y, Miki T, Nakamura Y, Sasano H, Satoh F
18.[O] Intratumoral heterogeneity of steroidogenesis in aldosterone-producing adenoma revealed by intensive double- and triple-immunostaining for CYP11B2/B1 and CYP17..[Mol Cell Endocrinol,422,(2016),57-63]Nakamura Y, Kitada M, Satoh F, Maekawa T, Morimoto R, Yamazaki Y, Ise K, Gomez-Sanchez CE, Ito S, Arai Y, Dezawa M, Sasano H
19.[O] Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism..[Hypertension,67(1),(2016),146-152]Monticone S, Satoh F, Dietz AS, Goupil R, Lang K, Pizzolo F, Gordon RD, Morimoto R, Reincke M, Stowasser M, Mulatero P
20.[O] A case of bilateral aldosterone-producing adenomas differentiated by segmental adrenal venous sampling for bilateral adrenal sparing surgery..[J Hum Hypertens,30(6),(2016),379-385]Morimoto R, Satani N, Iwakura Y, Ono Y, Kudo M, Nezu M, Omata K, Tezuka Y, Seiji K, Ota H, Kawasaki Y, Ishidoya S, Nakamura Y, Arai Y, Takase K, Sasano H, Ito S, Satoh F
Page: [1] [2] [3] [4] [5] [next]
BackTop
copyright(c)2005 Tohoku University